Search results
Roche and Ascidian Therapeutics partner to develop RNA editing therapeutics
BioPharma-Reporter· 23 hours agoAscidian Therapeutics and Roche have started a research collaboration and licensing agreement to...
Ascidian and Roche to develop RNA therapies for neurological diseases
Pharmaceutical Technology via Yahoo Finance· 2 days agoAscidian Therapeutics has entered a research partnership and licensing agreement with Roche to...
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
Zacks via Yahoo Finance· 2 days agoRoche (RHHBY) gets exclusive, target-specific rights to Ascidian's RNA exon editing technology for...
A new Dell Medical School study finds that PTSD and depression can change our brains
Gannett via AOL· 40 minutes agoOne-third were from people diagnosed with major depressive disorder. The final third were from brains of people who had no mental health diagnosis. The researchers looked at genetics,
Roche wades deeper into RNA waters, paying Ascidian $42M to develop exon editing drugs
FierceBiotech· 3 days agoRoche has added to its flotilla of RNA alliances, handing Ascidian Therapeutics $42 million upfront...
Roche partners with RNA editing biotech Ascidian
BioPharma Dive via Yahoo Finance· 3 days agoWhile the Swiss pharma recently pruned its neurology drug pipeline, it has shown interest in the possibilities of RNA-focused approaches like what...
Estimating The Intrinsic Value Of Avidity Biosciences, Inc. (NASDAQ:RNA)
Simply Wall St. via Yahoo Finance· 2 days ago(NASDAQ:RNA) as an investment opportunity...
Avidity Biosciences executive sells shares worth $385,972 By Investing.com
Investing.com· 13 hours agoIn recent trading activity, Teresa McCarthy, Chief Human Resources Officer at Avidity Biosciences,...
Zerlasiran shows promise in phase 2 study for cardiovascular risk By Investing.com
Investing.com· 22 hours agoSilence Therapeutics plc (NASDAQ:SLN), a biotech firm focusing on RNA interference (RNAi) therapies,...
NGS: the road to personalising cancer care
Medical Device Network via Yahoo Finance· 21 hours ago“The partnership enables us to support their 130,000 unique cancer patients across their three cancer sites, a population which reflects the broad...
